seqWell’s workflow and reagent engineering approach helps researchers harness the capacity of modern sequencing instruments to accelerate their research at scale.
At left, sequencing results obtained for sequencing 192 samples of simplified single-cell cDNA with plexWell (blue) and for Nextera™ reagents (gray). Input DNA was pre-normalized, whereas plexWell library was made from un-normalized amplified cDNA. Read count variation for plexWell showed 27% CV versus 71% CV for Nextera.
Joseph C. Mellor, Ph.D.
Co-founder and Chief Scientific Officer, seqWell
Jessica M. Smith, Ph.D.
Director of Bioinformatics, seqWell
Director of Product Management, seqWell